About this item:

503 Views | 304 Downloads

Author Notes:

Email: josephine@.hoh@yale.edu

Conceived and designed the experiments: VLP AJZ HJ CK J. Hoh.

Performed the experiments: VLP AJZ HJ CK SS J. Han XL.

Analyzed the data: VLP AJZ HJ CK SS XL MC ATD J. Hoh.

Contributed reagents/materials/analysis tools: JLT.

Histological analyses were performed by two independent laboratories of Julie White’s group at Sloan Kettering Pathology Core and Dr. Weimin Zhong’s group at Yale.

We are grateful to Stephen R. Viviano and Kaiyong Zou for their technical assistance, and to Drs. Marvin Sears, Gerald Shadel, Michael Crair, James Tsai, David Zenisek and Weimin Zhong for advice and discussions.

Monoclonal antibody against PAX6 (developed by Kawakami) was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa.

The authors have declared that no competing interests exist.

Research Funding:

This work was funded by Rosebay Medical Foundation and Yale Medical School Dean’s Research Fund to JHoh. No URL.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • SERINE-PROTEASE HTRA2/OMI
  • CYTOCHROME-C RELEASE
  • MND2 MUTANT MICE
  • M-AAA PROTEASE
  • PARKINSONS-DISEASE
  • STRESS-RESPONSE
  • CELL-DEATH
  • AUTOPHAGY
  • FUSION
  • OMI/HTRA2

Neural-Specific Deletion of Htra2 Causes Cerebellar Neurodegeneration and Defective Processing of Mitochondrial OPA1

Show all authors Show less authors

Tools:

Journal Title:

PLoS ONE

Volume:

Volume 9, Number 12

Publisher:

, Pages e115789-e115789

Type of Work:

Article | Final Publisher PDF

Abstract:

HTRA2, a serine protease in the intermembrane space, has important functions in mitochondrial stress signaling while its abnormal activity may contribute to the development of Parkinson's disease. Mice with a missense or null mutation of Htra2 fail to thrive, suffer striatal neuronal loss, and a parkinsonian phenotype that leads to death at 30-40 days of age. While informative, these mouse models cannot separate neural contributions from systemic effects due to the complex phenotypes of HTRA2 deficiency. Hence, we developed mice carrying a Htra2-floxed allele to query the consequences of tissue-specific HTRA2 deficiency. We found that mice with neural-specific deletion of Htra2 exhibited atrophy of the thymus and spleen, cessation to gain weight past postnatal (P) day 18, neurological symptoms including ataxia and complete penetrance of premature death by P40. Histologically, increased apoptosis was detected in the cerebellum, and to a lesser degree in the striatum and the entorhinal cortex, from P25. Even earlier at P20, mitochondria in the cerebella already exhibited abnormal morphology, including swelling, vesiculation, and fragmentation of the cristae. Furthermore, the onset of these structural anomalies was accompanied by defective processing of OPA1, a key molecule for mitochondrial fusion and cristae remodeling, leading to depletion of the L-isoform. Together, these findings suggest that HTRA2 is essential for maintenance of the mitochondrial integrity in neurons. Without functional HTRA2, a lifespan as short as 40 days accumulates a large quantity of dysfunctional mitochondria that contributes to the demise of mutant mice.

Copyright information:

© 2014 Patterson et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote